Venture Visionary Partners’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-10
Closed -$269 664
2022
Q2
$269 Buy
+10
New +$269 ﹤0.01% 1677